BNP Paribas Discount Zert ABBV 29.../ DE000PC56F64 /
8/30/2024 9:29:04 AM | Chg.- | Bid8:29:56 AM | Ask8:29:56 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
160.33EUR | - | 161.53 Bid Size: 206 |
161.63 Ask Size: 206 |
AbbVie Inc | - USD | 12/29/2025 | Call |
GlobeNewswire
8/19
TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults wit...
GlobeNewswire
8/15
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
8/9
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2...
GlobeNewswire
8/8
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
8/7
Alector Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
8/6
Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
8/1
Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire
8/1
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire
8/1
NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer
GlobeNewswire
7/31
Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of Directors
GlobeNewswire
7/31
Umoja Biopharma Announces FDA Clearance of IND Application for UB-VV111, a CD19 Directed in situ CAR...
GlobeNewswire
7/30
Montara Therapeutics Closes $8 Million Seed Round Led by SV Health Investors’ Dementia Discovery Fun...
GlobeNewswire
7/28
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzhei...
GlobeNewswire
7/25
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Tre...
GlobeNewswire
7/24
Emerging Gene Therapies Signal Transformative Shift in Retinal Disorder Treatment, According to Sphe...
GlobeNewswire
7/24
Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital